首页> 外文期刊>Trials >Internet-based cognitive behavioural therapy (iCBT) for posttraumatic stress disorder versus waitlist control: study protocol for a randomised controlled trial
【24h】

Internet-based cognitive behavioural therapy (iCBT) for posttraumatic stress disorder versus waitlist control: study protocol for a randomised controlled trial

机译:基于互联网的认知行为治疗(iCBT),用于创伤后应激障碍与候补对照:一项随机对照试验的研究方案

获取原文
           

摘要

Background This randomised controlled trial (RCT) with two parallel arms will evaluate the efficacy of an internet-delivered six-lesson 10-week cognitive behavioural therapy (iCBT) intervention for posttraumatic stress disorder (PTSD). It will also investigate the association between changes in PTSD symptoms, intolerance of uncertainty (IU) and emotion regulation. Methods/Design Patients with PTSD will be recruited via the research arm of a not-for-profit clinical and research unit in Australia and randomised to a treatment group or waitlist control group. The minimum sample size for each group (alpha 0.05, power 0.80 for a g of 0.47) was identified as 72, but 10?% more will be recruited to hedge against expected attrition. PTSD diagnosis will be determined using the PTSD module from the Mini International Neuropsychiatric Interview version 5.0.0. The PTSD Checklist – Civilian version (PCL-C) will be used to measure PTSD symptoms (the primary outcome measure), with the Intolerance of Uncertainty Scale 12-item version (IUS-12) and the Emotion Regulation Questionnaire (ERQ) used to measure intolerance of uncertainty and emotion regulation, respectively. The PCL-C will be administered to the treatment group before each lesson of the PTSD program and at 3-month follow-up. The IUS-12 and ERQ will be administered before lessons 1 and 4, at post-treatment and at 3-month follow-up. The waitlist control group will complete these measures at week 1, week 5 and week 11 of the waitlist period. PTSD program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at 3-month follow-up. Mediation analyses using PROCESS will be used to examine the association between change in PTSD symptoms over treatment and change in each of IU and emotion regulation ability in separate analyses. Discussion The current RCT seeks to replicate previous efficacy findings of iCBT for PTSD in a formally assessed PTSD sample from the general population. Findings may point to future lines of enquiry for the role of IU and emotion regulation in the mechanism of PTSD symptom change during CBT. Trial registration Australian New Zealand Clinical Trials Registry: ACTRN12614001213?639 , registered 18 November 2014. This trial protocol is written in compliance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.
机译:背景这项带有两个平行臂的随机对照试验(RCT)将评估互联网提供的为时6周,为期10周的认知行为疗法(iCBT)干预对创伤后应激障碍(PTSD)的疗效。它还将调查PTSD症状的变化,不确定性的不宽容(IU)和情绪调节之间的关联。方法/设计PTSD患者将通过澳大利亚一家非营利性临床和研究部门的研究部门招募,并随机分为治疗组或候补对照组。每组的最小样本量(α0.05,0.47 g的功效为0.80)被确定为72,但是将招募10%来对冲预期的损耗。将使用Mini International Neuropsychiatric Interview版本5.0.0中的PTSD模块确定PTSD诊断。 PTSD清单–平民版本(PCL-C)将用于测量PTSD症状(主要结果指标),不确定性量表的不容忍度12个项目版本(IUS-12)和情绪调节问卷(ERQ)用于分别测量不确定性和情绪调节的不宽容。在每次PTSD计划的课程之前和3个月的随访中,将PCL-C给予治疗组。 IUS-12和ERQ将在第1课和第4课之前,治疗后和3个月的随访中进行管理。等待列表对照组将在等待列表周期的第1周,第5周和第11周完成这些措施。 PTSD程序的功效将使用意向治疗混合模型确定。收益的维持将在3个月的随访中进行评估。使用PROCESS进行的调解分析将用于在单独的分析中检查PTSD症状变化与治疗之间的相关性以及每个IU的变化与情绪调节能力之间的关系。讨论当前的RCT试图在对普通人群进行正式评估的PTSD样本中复制iCBT对PTSD的功效。研究结果可能指向将来关于IU和情绪调节在CBT期间PTSD症状改变机制中的作用的研究方向。试验注册澳大利亚新西兰临床试验注册中心:ACTRN12614001213?639,于2014年11月18日注册。该试验方案的编写符合标准方案项目:介入试验的建议(SPIRIT)指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号